Purchases and Sales Made in Q4 2024 in Akero Therapeutics, Inc. (AKRO)
This table provides information about the institutional ownership of Akero Therapeutics, Inc. (AKRO) during Q4 2024. The information is specifically focused on institutions that hold shares of Akero Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-205K- 30.92% |
$5.48M - $7.23M
|
458K
$23.6M
|
|
|
Feb 14, 2025
Q4 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
SELL
|
- |
-404K- 30.97% |
$10.8M - $14.2M
|
900K
$46.4M
|
|
|
Feb 12, 2025
Q4 2024
|
Wellington Management Group LLP
Boston, MA |
SELL
|
- |
-520K- 6.58% |
$13.9M - $18.3M
|
7.38M
$380M
|
|
|
Feb 14, 2025
Q4 2024
|
Perceptive Advisors LLC
New York, NY |
SELL
|
- |
-529K- 30.86% |
$14.2M - $18.7M
|
1.19M
$61.1M
|
|
|
Feb 14, 2025
Q4 2024
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
SELL
|
- |
-630K- 48.46% |
$16.9M - $22.2M
|
670K
$34.5M
|
|
|
Feb 14, 2025
Q4 2024
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-1.04M- 14.74% |
$27.9M - $36.8M
|
6.03M
$311M
|
|
|
Feb 13, 2025
Q4 2024
|
Alkeon Capital Management LLC
New York, NY |
SELL
|
- |
-1.56M- 47.03% |
$41.8M - $55.2M
|
1.76M
$90.7M
|